Close
Nordic 9Nordic 9

Newton Biocapital (investor - Venture Capital)

Belgium newtonbiocapital.com
See something wrong or missing? Let us know
Offices:Bruxelles

Newton Biocapital is a venture capital investment fund that invests in the life sciences sector with a specialization in chronic diseases.

Average round investment:12.82M USD
Average number per year:1.2
Distribution: 2023 (2)2022 (1)2021 (1)2020 (1)
Portfolio companies: France AbolerIS PharmaFrance Adipo PharmaBelgium DeuterOncology
Mostly invests in: France France (3) Biotech (5)
See the entire list

Showing 3 of 5 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Newton Biocapital

Name Criteria
Belgium Gemma Frisius Fund
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
France Siparex
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Belgium Flanders Future Techfund (FFTF)
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Belgium InvestSud
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France, Belgium
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Netherlands Positron Ventures
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Germany SHS Capital
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Netherlands DSM Venturing
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
Belgium SRIW
82%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France, Belgium
  • Average number of deals per year: 2.8
  • Active last 12 months: Yes
United Kingdom Sweet Capital
82%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.8
  • Active last 12 months: Yes
France Xerys
82%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Top